France · Question · Question écrite
14916
Question 14916 — pharmacy and medications
Introduced
5 May 2026
Last action
—
Status
posée
Sponsors
—
Subjects
Discovery layer
Source updated
5 May 2026
Summary
Mr. Sébastien Saint-Pasteur draws the attention of the Minister of Health, Families, Autonomy and People with Disabilities to the conditions for structuring a French cannabis industry for medical use after the national experimentation phase. The experimentation with therapeutic cannabis, launched in 2021 and extended until March 31, 2026 to ensure continuity of care for included patients, made it possible to demonstrate the interest of this therapeutic option for certain serious pathologies such as chronic refractory pain, severe epilepsy or side effects of oncological treatments. Several French industrial players mobilized during this period to prepare for national production and processing, in order to limit dependence on imports and guarantee quality, traceable medicines that comply with regulations. European safety standards. As the June 2026 deadline approaches, the date on which a decree is expected before submission to the Council of State, many uncertainties persist over the precise timetable for publication of the regulatory texts necessary for the controlled generalization of cannabis for medical use. These repeated delays generate a detrimental wait-and-see attitude. They slow down the investments necessary for structuring a competitive industrial sector on the national territory, delay the security of supply and maintain uncertainty both for patients in therapeutic impasse and for the jobs and industrial sites involved in this diversification. In this context, he asks what is the precise timetable retained by the Government for the publication of the necessary decrees and what measures it is considering to lift quickly address these regulatory uncertainties, encourage investments in quality national production and reconcile public health issues with the objectives of industrial sovereignty and maintaining employment in the territories; These are structuring questions for the health of the French people and for the country's innovative industrial fabric.
Machine translation from French. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/17/questions/QANR5L17QE14916
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L17QE14916